These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 41522)

  • 21. Concanavalin A stimulates the Rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes.
    Valette L; Prigent AF; Némoz G; Anker G; Macovschi O; Lagarde M
    Biochem Biophys Res Commun; 1990 Jun; 169(3):864-72. PubMed ID: 2163636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanylate cyclase activity in human leukemic and normal lymphocytes. Enzyme inhibition and cytotoxicity of plant extracts.
    Takemoto DJ; Dunford C; Vaughn D; Kramer KJ; Smith A; Powell RG
    Enzyme; 1982; 27(3):179-88. PubMed ID: 6122565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic cuanosine 3'5' phosphate, guanylate cyclase and cyclic guanosine phosphodiesterase in the eye lens.
    Bizec JC; Klethi J; Mandel P
    Biochem Biophys Res Commun; 1982 May; 106(1):108-12. PubMed ID: 6125150
    [No Abstract]   [Full Text] [Related]  

  • 24. [The level of cyclic nucleotides and the activity of their phosphodiesterases in the peripheral blood lymphocytes in lung diseases during endolymphatic antibiotic therapy].
    Feshchenko IuI; Spizhenko IuP
    Ter Arkh; 1991; 63(8):7-10. PubMed ID: 1665248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cyclic GMP concentration and guanylate cyclase and cyclic GMP phosphodiesterase activities in proestrus rat after treatment with LH.
    Patwardhan VV; Lanthier A
    Horm Metab Res; 1987 Mar; 19(3):136-7. PubMed ID: 2883102
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils.
    Grady PG; Thomas LL
    Biochim Biophys Acta; 1986 Mar; 885(3):282-93. PubMed ID: 3004603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.
    Nishikawa M; Kanamori M; Hidaka H
    J Pharmacol Exp Ther; 1982 Jan; 220(1):183-90. PubMed ID: 6118429
    [No Abstract]   [Full Text] [Related]  

  • 29. The fate of 18O in guanosine monophosphate during enzymic transformations leading to guanosine 3',5'-monophosphate generation.
    Walseth TF; Graff G; Krick TP; Goldberg ND
    J Biol Chem; 1981 Mar; 256(5):2176-9. PubMed ID: 6109725
    [No Abstract]   [Full Text] [Related]  

  • 30. Patterns of cyclic nucleotides in normal and leukaemic human leucocytes.
    Peracchi M; Maiolo AT; Lombardi L; Catena FB; Polli EE
    Br J Cancer; 1980 Mar; 41(3):360-71. PubMed ID: 6104501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB; Hobbs AJ; MacAllister RJ
    Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cyclic 3',5'-nucleotide phosphodiesterase activity in myocardial infarction.
    Nagasaka A; Nishijima K; Hidaka H; Tanaka T; Yoshida S; Nakai A; Ohyama T; Mizuno Y
    Acta Cardiol; 1985; 40(6):613-20. PubMed ID: 3006409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.
    Epstein PM; Hachisu R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():303-24. PubMed ID: 6202124
    [No Abstract]   [Full Text] [Related]  

  • 34. Stimulation of guanosine 3',5'-monophosphate-phosphodiesterase activity by adrenocorticotropic hormone-activated increase of guanosine 3',5'-monophosphate in isolated adrenocortical carcinoma cells.
    Perchellet JP; Sharma RK
    Endocrinology; 1979 Oct; 105(4):879-83. PubMed ID: 225158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes.
    Hadden JW; Hadden EM; Haddox MK; Goldberg ND
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):3024-7. PubMed ID: 4342973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report.
    Naskalski JW; Uciński WS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M; Endo T; Kanayama T; Hidaka H
    J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).
    Claflin AJ; Vesely DL; Hudson JL; Bagwell CB; Lehotay DC; Lo TM; Fletcher MA; Block NL; Levey GS
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):989-93. PubMed ID: 24847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.